Ifp Advisors, Inc Vericel Corp Transaction History

Ifp Advisors, Inc

$2.91 Billion
Q4 2024

A detailed history of Ifp Advisors, Inc transactions in Vericel Corp stock. As of the latest transaction made, Ifp Advisors, Inc holds 3 shares of VCEL stock, worth $185. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Holding current value

$185

% of portfolio

0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 04, 2025	BUY	$40.05 - $59.11 $120 - $177	3 New	3 $0
Q2 2023 Aug 04, 2023	BUY	$29.0 - $38.37 $522 - $690	18 New	18 $0
Q4 2022 Feb 07, 2023	SELL	$17.65 - $27.37 $35 - $54	-2 Reduced 0.47%	420 $7,000
Q3 2022 Nov 08, 2022	BUY	$22.62 - $32.54 $497 - $715	22 Added 5.5%	422 $7,000
Q2 2022 Sep 06, 2022	BUY	$22.88 - $39.45 $9,152 - $15,780	400 New	400 $6,000
Q2 2022 Aug 12, 2022	SELL	$22.88 - $39.45 $9,152 - $15,780	-400 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$31.69 - $43.29 $12,676 - $17,316	400 New	400 $15,000
Q3 2021 Oct 06, 2021	SELL	$46.35 - $59.75 $0 - $0	0 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$47.2 - $67.81 $0 - $0	0 New	0 $0
Q1 2021 Apr 30, 2021	BUY	$30.93 - $59.48 $0 - $0	0 New	0 $0
Q4 2020 Jan 25, 2021	SELL	$18.53 - $31.5 $11,470 - $19,498	-619 Closed	0 $0
Q3 2020 Oct 29, 2020	BUY	$14.68 - $19.12 $9,086 - $11,835	619 New	619 $12,000
Q2 2020 Aug 05, 2020	BUY	$8.5 - $15.82 $0 - $0	0 New	0 $0
Q1 2020 May 12, 2020	BUY	$7.25 - $19.22 $0 - $0	0 New	0 $0
Q4 2019 Jan 17, 2020	BUY	$13.77 - $19.2 $0 - $0	0 New	0 $0
Q3 2019 Nov 07, 2019	BUY	$14.93 - $19.83 $0 - $0	0 New	0 $0
Q1 2019 May 15, 2019	SELL	$16.23 - $20.29 $1,623 - $2,029	-100 Closed	0 $0
Q4 2018 Jan 23, 2019	BUY	$10.77 - $18.44 $1,077 - $1,844	100 New	100 $1,000

Others Institutions Holding VCEL

# of Institutions

285

Shares Held

49.3M

Call Options Held

91.8K

Put Options Held

23.2K

View Full List

About Vericel Corp

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.92B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

More about VCEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Account